AI and digital tech open up new frontiers in neurology research
New digital technology and AI can further neurological research and clinical trials
Neurology, Dec 1, 2022
Pharmafile
Therapeutic areas in focus
Install App?
Pharmafile
magazine.pharmafile.com
This is how the Install App dialog will look like once your App goes live.
Latest Issues
view more
Trending
view more
Helping rare diseases emerge from the shadows to take centre stage
The rare disease treatment market has been rapidly changing and receive deserved recognition
Rare Diseases, Dec 1, 2022
How RNA-based therapeutics improve care and benefit patients
Patients can benefit from new RNA-based therapeutics for metabolic care
Cardiovascular, Dec 1, 2022
Looking to the future of neurology
Pharmafile speaks to UCB: UCB discuss the challenges facing neurology and how these can be overcome
Neurology, Dec 1, 2022
The power of partnership: Collaborating with PAOs for better clinical research
Patient advocacy organisations can form an effective partnership between clinical trials and patients for more efficient trials
Rare Diseases, Dec 1, 2022
Addressing inequalities in access to medicines in a post-COVID world
The challenge of cardiovascular disease: Daiichi Sankyo tells Pharmafile about their role in improving access to cardiovascular treatments and the prevention of CVD
Cardiovascular, Dec 1, 2022Rare Diseases
Rising to the unique challenges of rare diseases
Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases
Rare Diseases, Dec 1, 2022
The changing landscape of rare disease research
Pharmafile speaks to Chiesi Group: Chiesi Group tells Pharmafile about the challenges facing rare disease research and their hopes for the future of this area
Rare Diseases, Dec 1, 2022The power of partnership: Collaborating with PAOs for better clinical research
Patient advocacy organisations can form an effective partnership between clinical trials and patients for more efficient trials
Rare Diseases, Dec 1, 2022Helping rare diseases emerge from the shadows to take centre stage
The rare disease treatment market has been rapidly changing and receive deserved recognition
Rare Diseases, Dec 1, 2022
The combination treatment challenge
Takeda tells Pharmafile about the role of combination treatments in rare diseases, and strategies to make them more accessible
Rare Diseases, May 31, 2022
Rare diseases and exceptional solutions
Many advancements have been made within the rare disease field, including gene editing and viral delivery strategies
Rare Diseases, May 31, 2022Infectious Diseases
A targeted approach to developing targeted blood cancer therapies
Precision medicine and targetted solutions can be utilised to treat cancer, but how can this develop in the future?
Oncology, May 31, 2022
Supporting the challenges of innovative systemic treatments
How can the benefits of immunotherapy be maximised for each patient?
Oncology, May 31, 2022
NHS waiting lists: the second healthcare crisis?
Novartis UK tells Pharmafile how COVID-19 impacted patient access to oncology treatments, and how the pharma industry can support the NHS
Oncology, May 31, 2022
Embrace disruption: the changing landscape of clinical research
How can precision medicine and personalised treatments improve healthcare in Europe and worldwide?
Oncology, May 31, 2022
New treatments and new challenges: The oncology constant is change
The UK has seen many innovations in the healthcare sphere, many have which have been in oncology, but what are the next steps in this ever-evolving field?
Oncology, May 31, 2022Dermatology
view more
Scratching the surface of eczema care in the UK
Pharmafilespeaks to Allergy UK: Allergy UK explores the future of eczema diagnosis, treatment, and support
Dermatology, Dec 1, 2021
Dermatologically speaking: Finding new treatments for women
Organon discusses the ways in which women's skin conditions can be managed
Dermatology, Dec 1, 2021
Insight and oversight: Making the most of virtual platforms in dermatology
FIDE discuss the need for communication between patients and their HCPs, specifically with virtual platforms in mind, and how this can improve dermatology care
Dermatology, Dec 1, 2021
“The pain keeps me awake at night. I can’t cope with this anymore”
There have been significant advances in dermatological care, this article explores this as well as looking forward to what still needs to be done
Dermatology, Dec 1, 2021
Supporting dermatology and oncology services to build back better post-COVID-19
The COVID-19 pandemic has been challenging service-wide for the NHS, but the pharma industry can support patients and the NHS going forward
Dermatology, Dec 1, 2021Pain
view more
Pain management and pharmaceutical compounding
Pain management is key for both patient and HCP, but how can compounding medication aid in treatment?
Pain, May 31, 2022
Embracing transdermal technologies
Pharmafile speaks to Futura for their insights into the effective delivery of drugs for pain management and alternative technologies
Pain, May 31, 2022
Medical cannabis - The inhaled answer to cancer and non-cancer pain?
Pharmafile speaks to Sapphire Clinics: Sapphire Clinics discuss the benefits of medical cannabis for pain management and how this has changed in the last decade
Pain, May 31, 2022Pharmafile Archive
Browse older editions
Sign up to our Newsletters
Sign up to our newsletters and digital magazines
